{"id":"act-541468","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Headache"},{"rate":"5-10%","effect":"Nausea"},{"rate":"5-10%","effect":"Dizziness"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"It works by blocking the action of orexin, a neurotransmitter involved in regulating arousal, wakefulness, and appetite. This can help reduce symptoms of insomnia and other sleep disorders.","oneSentence":"ACT-541468 is a selective orexin receptor antagonist.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T03:18:51.587Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Insomnia"}]},"trialDetails":[{"nctId":"NCT07028697","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Daridorexant in Participants With Insomnia Disorder","status":"COMPLETED","sponsor":"Nxera Pharma Korea Co., Ltd.","startDate":"2024-12-04","conditions":"Insomnia Disorder","enrollment":164},{"nctId":"NCT05458193","phase":"PHASE1","title":"A Study to Investigate the Effects of Daridorexant on Nighttime Breathing in Patients With Shallow or Paused Breath During Sleep","status":"COMPLETED","sponsor":"Idorsia Pharmaceuticals Ltd.","startDate":"2022-08-17","conditions":"Obstructive Sleep Apnea of Adult","enrollment":20},{"nctId":"NCT03575104","phase":"PHASE3","title":"Study to Assess the Efficacy and Safety of ACT-541468 (Daridorexant) in Adult and Elderly Subjects Suffering From Difficulties to Sleep","status":"COMPLETED","sponsor":"Idorsia Pharmaceuticals Ltd.","startDate":"2018-05-29","conditions":"Insomnia Disorder","enrollment":924},{"nctId":"NCT03545191","phase":"PHASE3","title":"Study to Assess the Efficacy and Safety of ACT-541468 (Daridorexant) in Adult and Elderly Subjects With Insomnia Disorder","status":"COMPLETED","sponsor":"Idorsia Pharmaceuticals Ltd.","startDate":"2018-06-04","conditions":"Insomnia Disorder","enrollment":930},{"nctId":"NCT03679884","phase":"PHASE3","title":"Study to Assess the Long Term Safety and Tolerability of ACT-541468 (Daridorexant) in Adult and Elderly Subjects Suffering From Difficulties to Sleep","status":"COMPLETED","sponsor":"Idorsia Pharmaceuticals Ltd.","startDate":"2018-10-09","conditions":"Insomnia Disorder","enrollment":804},{"nctId":"NCT04250506","phase":"PHASE1","title":"A Study to Assess the Effect of Single Doses of Daridorexant on Electrocardiogram Parameters in Healthy Subjects","status":"COMPLETED","sponsor":"Idorsia Pharmaceuticals Ltd.","startDate":"2020-02-28","conditions":"Healthy","enrollment":36},{"nctId":"NCT04024332","phase":"PHASE1","title":"Study of the Way the Body Takes up, Distributes, and Gets Rid of ACT-541468 in Subjects With Abnormal Kidney Function Compared to Healthy Subjects","status":"COMPLETED","sponsor":"Idorsia Pharmaceuticals Ltd.","startDate":"2019-09-24","conditions":"Renal Insufficiency, Healthy","enrollment":16},{"nctId":"NCT03713242","phase":"PHASE1","title":"A Study to Evaluate the Pharmacokinetics of ACT-541468 in Subjects With Mild, Moderate, and Severe Hepatic Impairment","status":"COMPLETED","sponsor":"Idorsia Pharmaceuticals Ltd.","startDate":"2018-02-26","conditions":"Hepatic Impairment","enrollment":32},{"nctId":"NCT02841709","phase":"PHASE2","title":"Efficacy and Safety of ACT-541468 in Elderly Subjects With Insomnia Disorder","status":"COMPLETED","sponsor":"Idorsia Pharmaceuticals Ltd.","startDate":"2016-11-28","conditions":"Insomnia Disorder","enrollment":58},{"nctId":"NCT02839200","phase":"PHASE2","title":"Efficacy and Safety of ACT-541468 in Adult Subjects With Insomnia Disorder","status":"COMPLETED","sponsor":"Idorsia Pharmaceuticals Ltd.","startDate":"2016-10-04","conditions":"Insomnia Disorder","enrollment":360},{"nctId":"NCT03765294","phase":"PHASE1","title":"A Study to Investigate the Effects of ACT-541468 on Nighttime Respiratory Function in Patients With Mild to Moderate Obstructive Sleep Apnea","status":"COMPLETED","sponsor":"Idorsia Pharmaceuticals Ltd.","startDate":"2019-03-14","conditions":"Obstructive Sleep Apnea","enrollment":28},{"nctId":"NCT03892902","phase":"PHASE1","title":"A Clinical Study to Assess Next-day Driving Performance Following Administration of ACT-541468 in Middle-aged and Elderly Subjects","status":"COMPLETED","sponsor":"Idorsia Pharmaceuticals Ltd.","startDate":"2019-03-25","conditions":"Healthy","enrollment":56},{"nctId":"NCT03907215","phase":"PHASE1","title":"A Clinical Study to Examine the Drug-drug Interactions Between ACT-541468 and Citalopram in Healthy Male and Female Subjects","status":"COMPLETED","sponsor":"Idorsia Pharmaceuticals Ltd.","startDate":"2019-04-09","conditions":"Healthy","enrollment":24},{"nctId":"NCT03646864","phase":"PHASE1","title":"A Study to Evaluate the Effects of ACT-541468 on Respiration in Patients With Moderate Chronic Obstructive Pulmonary Disease","status":"COMPLETED","sponsor":"Idorsia Pharmaceuticals Ltd.","startDate":"2018-11-15","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":28},{"nctId":"NCT03657355","phase":"PHASE1","title":"Study to Evaluate the Abuse Potential of ACT-541468 in Healthy Recreational Drug Users","status":"COMPLETED","sponsor":"Idorsia Pharmaceuticals Ltd.","startDate":"2018-09-07","conditions":"Healthy Recreational Drug Users","enrollment":63},{"nctId":"NCT03799978","phase":"PHASE1","title":"A Clinical Study to Investigate the Food Effect on the Pharmacokinetics of ACT-541468 in Healthy Male Subjects","status":"COMPLETED","sponsor":"Idorsia Pharmaceuticals Ltd.","startDate":"2019-03-09","conditions":"Healthy","enrollment":20},{"nctId":"NCT03609775","phase":"PHASE1","title":"A Study to Investigate the Drug-drug Interactions Between ACT-541468 and Ethanol in Healthy Subjects","status":"COMPLETED","sponsor":"Idorsia Pharmaceuticals Ltd.","startDate":"2018-08-28","conditions":"Healthy","enrollment":22},{"nctId":"NCT02571855","phase":"PHASE1","title":"A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of ACT-541468 in Healthy Young Adults and Elderly Subjects","status":"COMPLETED","sponsor":"Idorsia Pharmaceuticals Ltd.","startDate":"2015-10-01","conditions":"Healthy Subjects","enrollment":85},{"nctId":"NCT03017495","phase":"PHASE1","title":"A Clinical Study to Investigate the Potential Interactions Between Food and ACT-541468 and Between ACT-541468 and Midazolam","status":"COMPLETED","sponsor":"Idorsia Pharmaceuticals Ltd.","startDate":"2017-01-01","conditions":"Healthy Subjects","enrollment":20},{"nctId":"NCT03101189","phase":"PHASE1","title":"A Study of ACT-541468 in Healthy Japanese and Caucasian Subjects","status":"COMPLETED","sponsor":"Idorsia Pharmaceuticals Ltd.","startDate":"2017-03-15","conditions":"Healthy Subjects","enrollment":40},{"nctId":"NCT02919319","phase":"PHASE1","title":"A Single Ascending Dose Study of ACT-541468 in Healthy Male Subjects","status":"COMPLETED","sponsor":"Idorsia Pharmaceuticals Ltd.","startDate":"2015-02-01","conditions":"Healthy Subjects","enrollment":40},{"nctId":"NCT02526888","phase":"PHASE1","title":"Pharmacokinetic Interaction Between Diltiazem and ACT-541468 in Healthy Subjects","status":"COMPLETED","sponsor":"Idorsia Pharmaceuticals Ltd.","startDate":"2015-09-01","conditions":"Healthy Subjects","enrollment":14},{"nctId":"NCT03339752","phase":"PHASE1","title":"A Study in Healthy Male Subjects to Investigate Whether Administration of ACT-541468 Can Affect the Fate in the Body (Amount and Time of Presence in the Blood) of Rosuvastatin","status":"COMPLETED","sponsor":"Idorsia Pharmaceuticals Ltd.","startDate":"2017-10-30","conditions":"Healthy Subjects","enrollment":20}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"ACT-541468","genericName":"ACT-541468","companyName":"Idorsia Pharmaceuticals Ltd.","companyId":"idorsia-pharmaceuticals-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"ACT-541468 is a selective orexin receptor antagonist. Used for Insomnia.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":12,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}